A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer
Journal
Breast Cancer Research
Journal Volume
23
Journal Issue
1
Date Issued
2021
Author(s)
Schmid P.
Sablin M.-P.
Bergh J.
Im S.-A.
Mart?nez N.
Neven P.
Lee K.S.
Morales S.
P?rez-Fidalgo J.A.
Adamson D.
Gon?alves A.
Prat A.
Jerusalem G.
Schlieker L.
Espadero R.-M.
Bogenrieder T.
Huang D.C.-L.
Crown J.
Cort?s J.
SDGs
Publisher
BioMed Central Ltd
Type
journal article